Maternal COVID-19 Vaccination Provides Some Protection for Infants
Some protection against COVID-19-related hospitalizations seen among infants, especially those aged younger than 3 months
Four Genetic Variants ID’d for Risk for Progressive Multifocal Leukoencephalopathy
All four risk variants were predicted to be deleterious and were located in two immune pathways
Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13
After 2010, all invasive pneumococcal infection serotypes were those not included in 13-valent pneumococcal conjugate vaccine
Respiratory Infections in Childhood Increased With Urbanized Living at Birth
Environmental factors, including breastfeeding and visible damp, are associated with risk for infections
Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
Revaccination should be considered for patients with chronic HCV who do not respond to HBV vaccination
Infection With Omicron Less Likely to Result in Post-COVID-19 Condition
No variation in risk for PCC seen based on number of vaccinations, but previous infection linked to reduced PCC risk
Sputum Purulence Can Predict Outcomes in Bronchiectasis
Patients with more purulent sputum experience more exacerbations and more severe exacerbations
BNT162b2 Vaccination Linked to Lower Risk for COVID-19 Encounters in Children Under 5
Vaccination linked to reduced odds ratio of COVID-19-related emergency department or urgent care encounter, outpatient visits
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone
Factors Identified for Readmission Among Children With ARDS
Respiratory and nonrespiratory complex chronic conditions, tracheostomy placement, LOS ≥14 days linked to readmission; one-year readmission probability was 30 percent
